Milford, CT, United States of America

David Evarts

This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Edgewell Personal Care Brands, LLC. Active years: 2018-2026.

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Milford, CT (US) (2018)
  • Stratford, CT (US) (2022)

Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of David Evarts

Introduction: David Evarts, a pioneering inventor hailing from Milford, CT (US), has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: David Evarts holds several patents in various fields, including telecommunications, renewable energy, and medical devices. His most recent patent is for a cutting-edge wireless communication technology that revolutionizes data transmission efficiency.

Career Highlights: Throughout his illustrious career, David Evarts has been recognized for his inventive spirit and problem-solving skills. He has received multiple awards for his innovative contributions to the industry and has been a keynote speaker at prestigious technology conferences worldwide.

Collaborations: David Evarts has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions. His collaborative efforts have led to the successful implementation of cutting-edge technologies in real-world applications.

Conclusion: David Evarts' relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor. His impact on the world of technology continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…